Christopher Prze, MD
Otolaryngology · Salem, ORNPI 1306224530
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.2%), food and beverage and education — rather than concentrated in one kind of arrangement. Stryker accounts for 61.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $3,161 and has fallen 99.3% since, to $22 in 2025.
Across 60 payments — averaging $79.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Zimmer Biomet$1K
- Medical Device Business Services, Inc.$350
- Intersect ENT, Inc.$130
- Acclarent, Inc$70
- Axogen$48
- plus $170 from 6 others
What the payments were for
- Travel & lodging$2,73257%
- Food & beverage$1,67635%
- Education$3507%
- Gifts$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 26 | $2,915 |
| Zimmer Biomet | 17 | $1,092 |
| Medical Device Business Services, Inc. | 3 | $350 |
| Intersect ENT, Inc. | 2 | $130 |
| Acclarent, Inc | 4 | $70 |
| Axogen | 1 | $48 |
| Aerin Medical Inc. | 1 | $38 |
| Medtronic | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Merck | 1 | $30 |
| Alk-abello, Inc | 1 | $22 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,776 in reported general payments places this provider in the 85th percentile of 128 otolaryngology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 100 | $2,750 |
| Cefdinir | 12 | $302 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $245 |
| Azelastine Hcl | 13 | $204 |
| Omeprazole | 17 | $202 |
| Famotidine | 14 | $190 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $92 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Salem
- Douglas SkaradaSalem$7K
- Suzanne StrandSalem$3K
- John DonovanSalem$666
- Mathew GeltzeilerPortland$221K
- Ryan LiPortland$160K
- Jeremiah AltPortland$89K
- Mark WaxPortland$20K
- Marcus MonroePortland$16K
- Joshua SchindlerPortland$8K
- Andrew BakerMilwaukie$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.